Summary by Futu AI
Recursion Pharmaceuticals, Inc. announced that Officer Michael Secora plans to sell 15,000 Class A shares on 12/10/2024, with an estimated market value of $116,324.39. The shares were originally acquired through a stock option exercise on 08/15/2023.This sale is part of a larger trading pattern. Over the past three months, Secora has sold a total of 90,000 shares in six separate transactions, generating gross proceeds of $606,864.38. These sales occurred between 09/10/2024 and 11/13/2024, with each transaction involving 15,000 shares.The planned sale on 12/10/2024 appears to be a continuation of this selling strategy, which was initiated on 03/01/2024 when the trading plan was adopted or instructions were given. This consistent selling pattern suggests a predetermined liquidation strategy rather than a response to specific market conditions.
Comment(0)
Reason For Report